BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37243900)

  • 1. Baseline predictors of fatigue and persistent fatigue in rheumatoid arthritis: A longitudinal observational study.
    Fazaa A; Boussaa H; Ouenniche K; Miladi S; Makhlouf Y; Belhadj S; Ben Abdelghani K; Laatar A
    Musculoskeletal Care; 2023 Dec; 21(4):1068-1074. PubMed ID: 37243900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.
    Lee YC; Cui J; Lu B; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME; Solomon DH
    Arthritis Res Ther; 2011 Jun; 13(3):R83. PubMed ID: 21651807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients.
    Lee HJ; Pok LSL; Ng CM; Yahya F; Sockalingam S; Tee YC; Raja J
    Int J Rheum Dis; 2020 Aug; 23(8):1088-1093. PubMed ID: 32597545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis.
    Campbell RC; Batley M; Hammond A; Ibrahim F; Kingsley G; Scott DL
    Clin Rheumatol; 2012 Apr; 31(4):717-22. PubMed ID: 22124789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
    Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
    J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
    Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
    RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: a longitudinal observational study, data from the ESPOIR cohort.
    Rodríguez-Muguruza S; Combe B; Guillemin F; Fautrel B; Olive A; Marsal S; Valero O; Rincheval N; Lukas C
    Scand J Rheumatol; 2020 Jul; 49(4):259-266. PubMed ID: 32351168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
    Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.
    Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
    Arthritis Rheumatol; 2017 Aug; 69(8):1566-1575. PubMed ID: 28425173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
    Castrejón I; Dougados M; Combe B; Fautrel B; Guillemin F; Pincus T
    J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.
    Bechman K; Tweehuysen L; Garrood T; Scott DL; Cope AP; Galloway JB; Ma MHY
    J Rheumatol; 2018 Nov; 45(11):1515-1521. PubMed ID: 30173149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Fatigue in Rheumatoid Arthritis Patients in Remission or in a Low Disease Activity State.
    Olsen CL; Lie E; Kvien TK; Zangi HA
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):1043-8. PubMed ID: 26555897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis.
    Fleischmann R; Hayes K; Ahn SW; Wan GJ; Panaccio MP; Karlsson D; Furst DE
    Rheumatol Ther; 2022 Apr; 9(2):435-446. PubMed ID: 34919213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
    Gerber LH; Furst G; Yarboro C; el-Gabalawy H
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
    Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
    J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort.
    Holdren M; Schieir O; Bartlett SJ; Bessette L; Boire G; Hazlewood G; Hitchon CA; Keystone E; Tin D; Thorne C; Bykerk VP; Pope JE;
    Arthritis Rheumatol; 2021 Jan; 73(1):53-60. PubMed ID: 32852109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.
    Strand V; Kaine J; Alten R; Wallenstein G; Diehl A; Shi H; Germino R; Murray CW
    Arthritis Res Ther; 2020 Oct; 22(1):243. PubMed ID: 33059710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.